King Faisal Specialist and Research Centre achieves world-first fully robotic liver transplant

The Organ Transplant Center of Excellence (OTCoE) team at King Faisal Specialist Hospital and Research Centre (KFSH&RC) has announced that it has successfully performed the world’s first fully robotic liver transplant.

The medical milestone marks KFSH&RC’s, a tertiary and quaternary healthcare provider in the Middle East, position as a global leader in minimally invasive transplant surgery.

In Saudi Arabia, a 66-year-old Saudi man underwent the transplant after suffering from an aggressive form of fatty liver disease called non-alcoholic liver cirrhosis (NASH) and hepatocellular carcinoma (HCC), the most common type of liver disease.

To conduct donor and recipient surgeries, KFSH&RC used state-of-the art technology to eliminate the need for a hybrid approach, as it was precise and the least invasive option.

The approach, which was adopted by the OTCoE, aims to provide patients with smaller incisions, reduced recovery times and significantly lower rates of complications such as infections and surgical issues.

Traditional liver transplantation usually involves major incisions, which can lead to prolonged hospital stays and patient discomfort. These surgeries can also results in complications in up to 50% of cases.

Dr Dieter Broering, executive director of the OTCoE at KFSH&RC, said: "With this remarkable feat, we at KFSH&RC reaffirm our commitment to pushing the boundaries of medical innovation and enhancing the quality of healthcare services offered to patients worldwide.

“The successful implementation of fully robotic liver transplants marks a pivotal moment in the history of organ transplantation and firmly positions KFSH&RC as a world-leading centre in this field."

Now recognised as a designated training centre for robotic transplant surgery, KFSH&RC collaborates with other medical institutions, fostering knowledge exchange and aiming to advance the understanding of minimally invasive transplant procedures globally.

In August this year, KFSH&RC performed a surgery using advanced robotic technology to implant electrodes into the brain of a patient with refractory epilepsy. It was the first procedure ever to be performed in the Middle East using robotic assistance to identify epilepsy foci.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!